The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s pharmaceutical sterility testing market report forecasts the pharmaceutical sterility testing market size to grow to $2.07 Billion by 2027, with a CAGR (compound annual growth rate) of more than 12%.

Learn More On The Pharmaceutical Sterility Testing Market Report 2023 – https://www.thebusinessresearchcompany.com/report/pharmaceutical-sterility-testings-global-market-report

Pharmaceutical Sterility Testing Market Size Forecast

The global pharmaceutical sterility testing market is expected to grow from $1.19 billion in 2022 to $1.29 billion in 2023 at a compound annual growth rate (CAGR) of 8.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The pharmaceutical sterility testing market is expected to grow from $2.07 billion in 2027 at a CAGR of 12.5%.

North America held the largest pharmaceutical sterility testing market share, and Middle East was the fastest-growing region in 2022.

Key Pharmaceutical Sterility Testing Market Driver ­– Increase In The Number Of Drug Launches And Rise In Investment In R&D

For instance, in March 2022, according to an article shared by Pharmaceutical Technology, a US-based independent source for information, insight, and analysis on bio/pharmaceutical formulation, the UK government has announced a $347 million (£260 million) commitment to advance research and development (R&D) and the creation of innovative treatments, tools, and diagnostics. Additionally, in December 2021, according to a report shared by IQVIA, a US-based provider of advanced analytics, technology solutions, and clinical research services, Over the next five years, until 2026, a total of 300 new medications are anticipated to be introduced; this is a large increase over the level observed on average over the previous ten years, and the drugs are anticipated to tilt toward specialty, niche, and orphan drugs. In the next five years, there will be a $196 billion increase in spending on new products, which will be roughly offset by a $188 billion decrease in brand spending owing to loss of exclusivity.

Request for A Sample Of The Global Pharmaceutical Sterility Testing Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2826&type=smp

Key Pharmaceutical Sterility Testing Market Trend – Introducing New Pharmaceutical Sterility Testing Products

Companies in the pharmaceutical testing market are introducing new pharmaceutical sterility testing products and services to enhance their product portfolio and increase their presence in the market. The companies are launching technologically superior outcomes and well-equipped services to utilize the growth potential of the rising pharmaceutical sterility market. For instance, in June 2022, STEMart, a US-based provider of integrated medical device CRO services, launched comprehensive microbiology and sterility testing for sterile, non-pyrogenic products. A variety of services are included in comprehensive microbiology and sterility testing, such as the Antibiotic Potency Test to evaluate the bioactivity or potency of specific antibiotics for medical devices.

Pharmaceutical Sterility Testing Market Segment

1) By Sample: Sterile Drugs, Medical Devices, Biologics, and Therapeutics

2) By Product Type: Instruments, Kits and Reagents, Services

3) By Type: In-House, Outsourcing

4) By Test Type: Sterility Testing, Bioburden Testing, and Bacterial Endotoxin Testing

5) By End- User: Compounding Pharmacies, Medical Devices Companies, Pharmaceutical Companies

Pharmaceutical Sterility Testing Market Major Players and Strategies

Major players in the pharmaceutical sterility testing market are Pacific Biolabs, STRERIS Corporation, Boston Analytical, Gibraltar Laboratories, Sartorius AG, Solvias AG, SGS AG, Toxikon Inc., Pace Analytical Services LLC., Charles River Laboratories International Inc., Nelson Laboratories Inc., Rapid Micro Biosystems Inc., BioMerieux, Merck KGaA, Wuxi AppTec, Sotera Health LLC., Dynalabs, and Infinity.

The Pharmaceutical Sterility Testing Global Market Report 2023 covers regional data on pharmaceutical sterility testing market size, pharmaceutical sterility testing market trends and drivers, opportunities, strategies, and pharmaceutical sterility testing market competitor analysis. The countries covered in the pharmaceutical sterility testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Pharmaceutical sterility testing refers to a test that is intended to show if biological parenterals made for human use contain extraneous, viable contaminating microorganisms or not. All pharmaceutical items used on patients by medical professionals must be of the highest quality and extremely safe. Otherwise, it could harm the patients. Testing for sterility assures that the offered product is suitably sterile.

View More Reports Related To The Pharmaceutical Sterility Testing Market –

Pharmaceutical Drugs Global Market Report 2023

Pharmaceutical Drug Delivery Global Market Report 2023

Pharmaceutical Logistics Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: